Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:04 PM
Ignite Modification Date:
2025-12-24 @ 10:04 PM
NCT ID:
NCT00409435
Eligibility Criteria:
Inclusion Criteria:
Diagnosis of postural tachycardia syndrome using the following criteria:
* Orthostatic heart rate increment greater than or equal to 30 beats per minute (bpm) within 5 minutes of head-up tilt.
* Symptoms of orthostatic intolerance. These include weakness, lightheadedness, blurred vision, nausea, palpitations, and difficulty with concentration and thinking.
Both criteria must be fulfilled.
Exclusion Criteria:
* Pregnant or lactating women
* Presence of failure of other organ systems or systemic illness that could affect autonomic function or the patient's ability to cooperate with the study
* Hypothyroidism or hyperthyroidism
* Clinically significant coronary artery disease
* Medications that could interfere with autonomic testing
* Previous treatment with pyridostigmine for POTS. Patients must not have taken pyridostigmine in the past month
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
15 Years
Maximum Age:
55 Years
Study:
NCT00409435
Study Brief:
Protocol Section:
NCT00409435